Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient

Leuk Res. 2008 Feb;32(2):363-5. doi: 10.1016/j.leukres.2007.03.014. Epub 2007 Apr 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Fatal Outcome
  • Hodgkin Disease / drug therapy
  • Hodgkin Disease / genetics
  • Hodgkin Disease / pathology*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Male
  • Middle Aged
  • Mutation
  • Neoplasms, Second Primary / pathology*
  • Rituximab
  • Vidarabine / analogs & derivatives
  • Vidarabine / therapeutic use
  • ZAP-70 Protein-Tyrosine Kinase / metabolism*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • ZAP-70 Protein-Tyrosine Kinase
  • Vidarabine
  • fludarabine